Clinical TrialA dual amylin and calcitonin receptor agonist inhibits pain behavior and reduces cartilage pathology in an osteoarthritis rat model
-
Add time:08/29/2019 Source:sciencedirect.com
SummaryObjectivesPain and disability are the main clinical manifestations of osteoarthritis, for which only symptomatic therapies are available. Hence, there is a need for therapies that can simultaneously alter disease progression and provide pain relief. KBP is a dual amylin- and calcitonin-receptor agonist with antiresorptive and chondroprotective properties. In this study we investigated the effect of KBP in a rat model of osteoarthritis.
We also recommend Trading Suppliers and Manufacturers of AMYLIN (8-37) (RAT) (cas 138398-61-5). Pls Click Website Link as below: cas 138398-61-5 suppliers
Prev:Original articleThe protective effect of Azadirachta excelsa leaves extract and quercetin treatment on the learning and memory impairments in relation with insulin and amylin levels in the brain of streptozotocin-induced diabetic rats
Next:BZ043, a novel long-acting amylin analog, reduces gastric emptying, food intake, glycemia and insulin requirement in streptozotocin-induced diabetic rats) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Amylin receptor ligands reduce the pathological cascade of Alzheimer's disease09/01/2019
- Effects of intrathecal amylin on formalin-induced nociception and on cAMP accumulation in the rat embryonic spinal cells08/31/2019
- BZ043, a novel long-acting amylin analog, reduces gastric emptying, food intake, glycemia and insulin requirement in streptozotocin-induced diabetic rats08/30/2019
- Original articleThe protective effect of Azadirachta excelsa leaves extract and quercetin treatment on the learning and memory impairments in relation with insulin and amylin levels in the brain of streptozotocin-induced diabetic rats08/28/2019
- Protein aggregates and proteostasis in aging: Amylin and β-cell function08/27/2019
- ReviewAmylin – Its role in the homeostatic and hedonic control of eating and recent developments of amylin analogs to treat obesity08/26/2019
- Amylin and diabetic cardiomyopathy – amylin-induced sarcolemmal Ca2 + leak is independent of diabetic remodeling of myocardium☆08/25/2019
- Focused reviewInteraction of amylin species with transition metals and membranes08/24/2019
- Fibril formation and toxicity of the non-amyloidogenic rat amylin peptide08/23/2019
